Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial-Reference-Cited by-同舟云学术

Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial

Published:2024-09 Issue:9 Volume:24 Page:1025-1036
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Juraska Michal,Early Angela M,Li Li,Schaffner Stephen F,Lievens Marc,Khorgade Akanksha,Simpkins Brian,Hejazi Nima S,Benkeser David,Wang Qi,Mercer Laina D,Adjei Samuel,Agbenyega Tsiri,Anderson Scott,Ansong Daniel,Bii Dennis K,Buabeng Patrick B Y,English Sean,Fitzgerald Nicholas,Grimsby Jonna,Kariuki Simon K,Otieno Kephas,Roman François,Samuels Aaron M,Westercamp Nelli,Ockenhouse Christian F,Ofori-Anyinam Opokua,Lee Cynthia K,MacInnis Bronwyn L,Wirth Dyann F,Gilbert Peter B,Neafsey Daniel E

Funder

GlaxoSmithKline

Bill and Melinda Gates Foundation

GlaxoSmithKline Biologicals SA

Broad Institute

PATH

Bundesministerium für Bildung und Forschung

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Reference28 articles.

1. Malaria parasites in the asymptomatic: looking for the hay in the haystack;Galatas;Trends Parasitol,2016

2. Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial;Samuels;Lancet Infect Dis,2022

3. Genetic diversity and protective efficacy of the RTS,S/AS01 malaria vaccine;Neafsey;N Engl J Med,2015

4. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial;Oneko;Nat Med,2021

5. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: a randomized, placebo-controlled trial with controlled human malaria infection;Murphy;PLoS Pathog,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymptomatic parasitemia and RTS,S vaccine efficacy;The Lancet Infectious Diseases;2024-09

2. The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria;Nature Reviews Immunology;2024-06-11